Krsnaa Diagnostics announced it has secured agreements with the Ranchi Institute of Neuro-Psychiatry & Allied Services (RINPAS) and Sadar Hospital, Ranchi.
These public-private partnerships involve setting up and operating radiology and pathology labs. The move is expected to strengthen the company’s presence in India’s healthcare infrastructure, adding value to its integrated diagnostic services.
Krsnaa Diagnostics Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Wed, Oct 9 2024
|
₹834.15
|
₹845.95
|
|
Tue, Oct 8 2024
|
₹777.00
|
₹827.05
|
|
Mon, Oct 7 2024
|
₹859.30
|
₹781.40
|
-8.15%
|
Fri, Oct 4 2024
|
₹859.60
|
₹850.75
|
-0.51%
|
Thu, Oct 3 2024
|
₹845.10
|
₹855.15
|
|
Tue, Oct 1 2024
|
₹850.00
|
₹854.95
|
|
Mon, Sep 30 2024
|
₹822.05
|
₹841.85
|
|
Fri, Sep 27 2024
|
₹848.00
|
₹829.05
|
-1.31%
|
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.